Copyright © 2001 by the European Society of Cardiology.
Editorials
Economics of coronary stenting and GPIIb/IIIa blockade
Emory Center for Outcomes Research, Emory University, Atlanta, Georgia, U.S.A.
References
- N Engl J Med. 1994;330:956961
[Abstract/Free Full Text] - Circulation. 1997;96:14451453
[Abstract/Free Full Text] - N Engl J Med. 1997;336:16891696
[Abstract/Free Full Text] - Lancet. 1998;352:8792[Web of Science][Medline]
- Zwart-van Rijkom JEF, van Hout BA. Cost-efficacy in interventional cardiology: results from the EPISTENT study. Eur Heart J. 2001;22:14761484
[Abstract/Free Full Text] - Weintraub WS, Thompson TD, Culler S. Targeting patients undergoing angioplasty for thrombus inhibition: a cost-effectiveness and decision support model. Circulation. 2000;102:392398
[Abstract/Free Full Text] - Mark DB, Talley JD, Topol EJ. Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. Circulation. 1996;94:629635
- Weintraub WS, Culler S, Boccuzzi SJ. Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. J Am Coll Cardiol. 1999;34:10611066
[Abstract/Free Full Text] - Lincoff, AM, Mark, DB, Tcheng, JE, Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: Results from the EPILOG Circulation. 2000, 102, 2923, 9
- Cohen DJ, Krumholz HM, Sukin CA. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: results from a randomized clinical trial. Circulation. 1995;92:24802487
[Abstract/Free Full Text] - Loomes G, McKenzie L. The use of QALYs in health care decision making. Soc Sci Med. 1989;28:299308[CrossRef][Web of Science][Medline]
- Cook TA, O'Regan M, Galland RB. Quality of life following percutaneous transluminal angioplasty for claudication. Euro J Vasc Endovasc Surg. 1996;11:191194[CrossRef][Web of Science][Medline]
- Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press; 1990. p. 1289
- Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press; 1990. p. 1278
- Borna S, Sundaram S. An approach to allocating limited health resources. J Health Soc Behav. 1999;11:8594
- Gold, MR, Siegel, JE, Russell, LB, Weinstein, MC, Cost-effectiveness in health and medicine, New York, Oxford University Press, 1996
This article has been cited by other articles:
![]() |
M. J. Eisenberg Drug-Eluting Stents: The Price Is Not Right Circulation, October 17, 2006; 114(16): 1745 - 1754. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
